Process for predicting the prognosis of squamous cell lung...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07927805

ABSTRACT:
Disclosed in this specification is a method for predicting the prognosis of squamous cell lung cancer by observing regulatory changes in select miRNA sequences. These sequences may include hsa-mir-146b, hsa-mir-191, hsa-mir-206, hsa-mir-299-3p, hsa-mir-155, hsa-mir-15a, hsa-mir-122a, hsa-mir-513, hsa-mir-184, hsa-mir-511, hsa-mir-100, hsa-mir-10a, hsa-mir-453, hsa-mir-379, hsa-mir-202, hsa-mir-21, hsa-mir-126, hsa-mir-494, hsa-mir-432, hsa-mir-370, and combinations of these sequences.

REFERENCES:
patent: 2007/0299030 (2007-12-01), Dmitrovsky et al.
patent: 2008/0076674 (2008-03-01), Litman et al.
patent: 2005 192484 (2005-07-01), None
patent: WO 2005/111211 (2005-11-01), None
patent: WO 2007/081720 (2007-07-01), None
patent: WO 2007/081740 (2007-07-01), None
patent: WO2009/049129 (2009-04-01), None
Weimer et al., The role of microRNAs in cancer: No small matter, European Journal of Cancer, 2007, pp. 1529-1544, vol. 43, Elsevier Ltd.
Garzon et al., MicroRNA expression and function in cancer, Trends in Molecular Medicine, 2006, pp. 580-587, vol. 12, No. 12, Elsevier Ltd.
Nasser et al., Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer, The Journal of Biological Chemistry, Nov. 28, 2008, pp. 33394-33405, vol. 283, No. 48, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Tusher et al., Significance Analysis of Microarrays Applied to the Ionizing Radiation Response, PNAS, Apr. 24, 2001, pp. 5116-5121, vol. 98, No. 9, National Academy of Sciences.
Perry et al., Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1-β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells, The Journal of Immunology, 2008, pp. 5689-5698, vol. 180, The American Association of Immunologists, Inc.
Yan et al., MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis, RNA Journal, Sep. 23, 2008, pp. 2347-2360, vol. 14, Cold Spring Harbor Laboratory Press.
Dillhoff et al., MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival, J Gastrointest Surg, 2008, pp. 2171-2176, vol. 12, The Society for Surgery of the Alimentary Tract.
Hayashita et al., A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation, Cancer Res 2005, Nov. 1, 2005, pp. 9628-9632, vol. 65 (21), American Association for Cancer Research.
Taganov et al., Nf-kB-dependent induction of microRNA miR-146, and inhibitor targeted to signaling proteins of innate immune responses, PNAS, Aug. 15, 2006, pp. 12481-12486, vol. 103, No. 33, National Academy of Sciences of the USA.
Peltier et al., Normalization of microRNA expression levels in quantitave RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues, RNA Journal, 2008, pp. 844-852, vol. 14, Cold Spring Harbor Laboratory Press.
Nikiforova et al., MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility, J Clin Endocrinol Metab., May 2008, pp. 1600-1608, vol. 93 (5), The Endocrine Society.
Chen et al., MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma, Modern Pathology, 2008, pp. 1139-1146, vol. 21, USCAP, Inc.
Connolly et al., Elevated Expression of the miR-17-92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype, The American Journal of Pathology, Sep. 3, 2008, pp. 856-864, vol. 173, No. 3, The American Society for Investigative Pathology.
Calin et al., A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia, The New England Journal of Medicine, Oct. 27, 2005, pp. 1793-1801, vol. 353, No. 17, The New England Journal of Medicine, Boston.
International Searching Authority, International Search Report and Written Opinion in PCT No. PCT/US2008/081809, Mailed Apr. 1, 2009.
Jay et al., miRNA profiling for diagnosis and prognosis of human cancer, DNA and Cell Biology, May 5, 2007, pp. 1044-5498, vol. 26, No. 5, Mary Ann Liebert, Inc.
Yanaihara et al., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, Mar. 2006, pp. 189-198, vol. 9, No. 3, Elsevier Inc.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for predicting the prognosis of squamous cell lung... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for predicting the prognosis of squamous cell lung..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for predicting the prognosis of squamous cell lung... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2686689

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.